newsfilter
← Latest News
GlobeNewswire·

Histogen Reports Third Quarter 2021 Earnings and Provides Business Update

Phase 1/2 Study of HST 003 for Cartilage Regeneration in the Knee On-Going with Top-Line Data Expected in the Second Half of 2022 IND Filing for HST 004 for Spinal Disc Repair Anticipated in the Third Quarter of 2022 Pre-Clinical Proof-of-C